Accessibility Menu
Bruker logo

Bruker(NASDAQ) BRKR

Market Cap$9.05BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2000)+169%
5 Year-34%
1 Year+103%
1 Month+18%
Premium Feature
Moneyball Superscore
66/100
$58.43
-1.65%
-0.98Today
After hours$58.48+$0.05 (+0.09%)
Bruker last closing stock price
MetricPriceDate
Last closeUSD 59.412026-09-03
Bruker stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0.27%USD 59.252026-08-27
1 month+18.11%USD 50.302026-08-04
3 month+5.45%USD 56.342026-06-05
Year to date+26.41%USD 47.002025-12-31
1 year+103.42%USD 29.212025-09-03
3 year-8.9%USD 65.222023-09-01
5 year-33.87%USD 89.832021-09-03
Since inception+168.91%USD 22.092000-08-04

Bruker Financials at a Glance

Market Cap

$9.05BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$3.50B

Net Income (TTM)

-$71.20M

EPS (TTM)

-$0.70

P/E Ratio

-84.46

Dividend

$0.20

Beta (Volatility)

1.11 (Average)

Price

$58.43

Volume

1,334,174

Open

$59.32

Previous Close

$58.50

Daily Range

$58.26 - $59.79

52-Week Range

$29.84 - $65.30

Estimated Earnings Date

Nov 2, 2026

BRKR News

SellAlert-Green.png

Why a $30 Million Bruker Stock Trim Matters Amid an 18% Slide

Jonathan PoncianoDec 26, 2025
Person in a lab gazing into a microscope

Why Bruker Stock Slumped Monday

Eric VolkmanNov 4, 2025
lab test tubes and pipette.jpg

Why This Investment Advisor Sold Off Its $3.6 Million Bruker Stake

Jonathan PoncianoNov 4, 2025
Person in a lab gazing into a microscope

Why Bruker Stock Tumbled by Almost 12% Wednesday

Eric VolkmanSep 4, 2025
Foolcom-Featured.png

Bruker (BRKR) Q2 Revenue Slips 0.4%

Motley Fool Markets TeamAug 4, 2025
GettyImages-598131196

Will Bruker’s Stock Keep Climbing?

David HaenJan 16, 2020
GettyImages-1138911813

Why Bruker Jumped 12.6% Today

Todd CampbellMay 3, 2019
lab scientists GettyImages-470913492

Why Bruker Corp. Is Crashing 12% Today

Todd CampbellAug 3, 2016
Page 1

BRKR: Motley Fool Moneyball Superscore

66

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bruker

Bruker Corporation makes tools that help scientists see tiny things. These machines help doctors find diseases and make new medicines. The company also makes materials for advanced energy and physics.

Exploring the Invisible World

  • BSI CALID: Systems used to identify chemical substances and diagnose infections; revenue was $310.3 million in the three months ended June 30, 2026.
  • BSI NANO: High-powered microscopes and X-ray tools used for materials research and semiconductor manufacturing; revenue was $261.3 million in the three months ended June 30, 2026.
  • BSI BioSpin: Imaging and analysis tools used in medical research and drug development; revenue was $195.7 million in the three months ended June 30, 2026.
  • Bruker Energy and Supercon Technologies: Superconducting materials that conduct electricity without loss for energy and physics projects; revenue was $74.2 million in the three months ended June 30, 2026.

Mapping a New Path

  • Reorganized reportable segments in the third quarter of 2026 to focus on biosystems and microbiology diagnostics.
  • Merged the Bruker Cellular Analysis business into the Bruker Spatial Biology division on April 1, 2026.
  • Recognized a $12.2 million gain from remeasuring an equity interest in Tofwerk during the six months ended June 30, 2026.
  • Submitted refund requests for tariffs paid during 2025 following a U.S. Supreme Court ruling in early 2026.

A Global Science Engine

Bruker operates major research and manufacturing centers across Europe, Asia, and North America to support its global customer base. The company develops advanced analytical solutions that serve a wide range of markets from semiconductor manufacturing to clinical disease diagnostics.

Measuring Recent Performance

  • Revenue was $838.5 million in the three months ended June 30, 2026, up 5.2% year over year.
  • Operating loss was $65.3 million in the three months ended June 30, 2026, primarily due to $134.9 million in goodwill impairment charges.
  • Non-GAAP free cash flow was negative $59.2 million for the six months ended June 30, 2026.
  • Market capitalization reached $9.2 billion in Q2 2026, up 46.6% year over year.

Evolution at a Glance

Bruker has evolved from a specialized scientific instrument maker into a broader provider of diagnostic and life science solutions. By reorganizing its business segments, the company aims to improve its focus on high-growth areas like microbiology and biotechnology.

AI Generated • Aug 6, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

11,085

CEO

Frank H. Laukien, PhD

Website

www.bruker.com

Headquarters

Billerica, MA 01821, US

BRKR Financials

Key Financial Metrics (TTM)

Gross Margin

46.69%

Operating Margin

3.61%

Net Income Margin

-2.03%

Return on Equity

-2.92%

Return on Capital

5.25%

Return on Assets

-1.18%

Earnings Yield

-1.18%

Dividend Yield

0.34%

Payout Ratio

-76.83%

Stock Overview

Market Cap

$9.05BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

152.36M

Volume

1.33M

Avg. Volume

2.28M

Financials (TTM)

Gross Profit

$1.63B

Operating Income

$126.50M

EBITDA

$247.70M

Operating Cash Flow

$190.40M

Capital Expenditure

-$96.50M

Free Cash Flow

$93.90M

Cash & ST Invst.

$184.90M

Total Debt

$1.92B

Bruker Performance Analysis

Bruker annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 2,530,700,0004.7%
20232023-12-31USD 2,964,500,00017.1%
20242024-12-31USD 3,366,400,00013.6%
20252025-12-31USD 3,436,500,0002.1%
Bruker sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-307.9%
Q42025-12-3113.6%
Q12026-03-31-15.7%
Q22026-06-301.8%
Bruker annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 1.999.5%
20232023-12-31USD 2.9046.2%
20242024-12-31USD 0.76-73.9%
20252025-12-31USD -0.15N/A
Bruker sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-920.0%
Q42025-12-31123.9%
Q12026-03-31-76.6%
Q22026-06-30-1890.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$838.50M

+5.2%

Gross Profit

$416.00M

+16.2%

Gross Margin

49.61%

N/A

Market Cap

$9.05BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$816.57K

N/A

Employees

11,085

N/A

Net Income

-$52.00M

-784.2%

EBITDA

$17.30M

-76.1%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$184.90M

+101.0%

Total Debt

$1.92B

-21.3%

Accounts Receivable

$875.40M

+18.5%

Inventory

$1.12B

-8.1%

Long Term Debt

$1.81B

-23.7%

Short Term Debt

$101.00M

+81.3%

Return on Assets

-1.18%

N/A

Return on Invested Capital

2.61%

N/A

Free Cash Flow

-$106.20M

+28.6%

Operating Cash Flow

-$77.40M

+39.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TGTXTG Therapeutics, Inc.
$55.99-1.28%
GKOSGlaukos Corporation
$177.47-1.60%
KRYSKrystal Biotech, Inc.
$358.24-3.56%
CHEChemed Corporation
$519.84-0.88%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.15-0.12%
NVDANvidia
$230.36+0.01%
PATHUiPath
$15.19-0.17%
INTCIntel
$95.80+0.05%

Questions About BRKR

What is the current price of Bruker?

Bruker is trading at $58.50 per share.

What is the 52-week range for Bruker?

Over the past 52 weeks, Bruker has traded between $29.84 and $65.30.

How much debt does Bruker have?

As of the most recent reporting period, Bruker reported total debt of $1.82B.

How much cash does Bruker have on hand?

Bruker reported $184.90M in cash and cash equivalents in its most recent financial results.

What is Bruker’s dividend yield?

Bruker currently has a dividend yield of 0.34%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services